Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 May 20;224(11):1907–1915. doi: 10.1093/infdis/jiab243

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Published by Oxford University Press for the Infectious Diseases Society of America 2021.

This work is written by (a) US Government employee(s) and is in the public domain in the US.

PMC Copyright notice

Figure 2. — Antibody responses by baseline malaria parasitemia (present vs absent) and by sex, at baseline and 1, 6 and 9–12 months after vaccination with recombinant vesicular stomatitis virus–Zaire Ebola virus envelope glycoprotein (GP) vaccine. Results from the immunogenicity substudy of the Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE) and based on analysis of covariance adjusted for the GP-ELISA GMTs and baseline malaria status by visit and sex. Abbreviations: CI, confidence interval; GMT, geometric mean titer; PRNT, plaque reduction neutralization test.